Adaptive Biotechnologies IPO

Adaptive Biotechnologies is a biotechnology company specializing immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.

Register for Details

For more details on financing and valuation for Adaptive Biotechnologies, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Adaptive Biotechnologies's ticker symbol?

Adaptive Biotechnologies does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Adaptive Biotechnologies's stock price?

The stock price for Adaptive Biotechnologies will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Adaptive Biotechnologies Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/4/2018 Series F-1 $1.35B $XXX.XX $XXX.XX
5/6/2015 Series F $1.08B $XXX.XX $XXX.XX
1/22/2015 Series E1 $652.13MM $XXX.XX $XXX.XX
1/21/2015 Series E $321.37MM $XXX.XX $XXX.XX
7/29/2014 Series D $261.89MM $XXX.XX $XXX.XX
7/9/2013 Series C $76.08MM $XXX.XX $XXX.XX
6/2/2011 Series B $49.04MM $XXX.XX $XXX.XX
3/24/2010 Series A $27.52MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Adaptive Biotechnologies

What is Adaptive Biotechnologies funding to date?

Adaptive Biotechnologies has raised $561.37MM with the following series:
$27.52MM for Series A, $49.04MM for Series B, $76.08MM for Series C, $261.89MM for Series D, $321.37MM for Series E, $652.13MM for Series E1, $1.08B for Series F, $1.35B for Series F-1

When was Adaptive Biotechnologies founded?

Adaptive Biotechnologies was founded in 2009.

Can you invest in Adaptive Biotechnologies?

Adaptive Biotechnologies is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Adaptive Biotechnologies share pre-IPO?

If you own Adaptive Biotechnologies pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Is Adaptive Biotechnologies a publicly traded company?

Adaptive Biotechnologies is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Adaptive Biotechnologies in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector
 
 
Sector
Last Round Est. Valuation
$500MM